EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessment of rapid bedside point of care diagnostic utility of cartridge-based nucleic acid amplification test (CBNAAT) in the diagno

Ashish Kumar Gupta, Prashant Yadav, Somnath Bhattacharya, Aditya Kumar Gautam, Adesh Kumar

The Journal of Association of Chest Physicians · 2026-01 · 14 (1) · 27-32

DOI: 10.4103/jacp.jacp_51_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Association of Chest Physicians, online erschienen am 24.04.2026. Verfasst von Ashish Kumar Gupta und 4 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Extrapulmonary tuberculosis poses a great challenge in the diagnosis and management due to the paucibacillary nature of the disease and limited tests available for early diagnosis. Tuberculous lymphadenopathy is the most common extrapulmonary manifestation of tuberculosis (TB). The Xpert mycobacterium tuberculosis/rifampicin (MTB/RIF) assay or cartridge-based nucleic acid amplification test (CBNAAT) for Mycobacterium is a rapid, automated, molecular assay, along with bedside fine needle aspiration cytology (FNAC) of the lymph nodes, together can form an excellent early screening tool for diagnosis and treatment initiation for TB.

Aim

To assess the early and rapid diagnostic accuracy of CBNAAT in the diagnosis of TB lymphadenitis by bedside FNAC procedure at a rural center. Methodology: This prospective observational diagnostic accuracy study [FNAC-Fine needle Aspiration Smear for Tuberculosis (FAST)] was conducted from January 2024 to June 2025 among 61 patients clinically suspected of lymph node TB. Bedside FNAC was performed on lymph nodes from the neck, axilla, or inguinal regions. Samples were tested using CBNAAT, liquid culture via BACTEC MGIT 960, and acid-fast bacilli (AFB) staining with Ziehl-Neelsen and Auramine methods. Mycobacterial culture served as the reference standard for comparison.

Results

Most patients were young adults (20–40 years, 65.6%) with a female predominance (67.2%). CBNAAT was positive in 62.3% of cases, while culture confirmed TB in 47.5% of cases. Granulomatous lymphadenitis was observed in 83.6% of cases, with 72.5% CBNAAT positivity and 6.5% rifampicin resistance among these. Reactive lymphadenitis cases were mostly negative on culture and CBNAAT. AFB staining detected only 20% of cases.

Conclusion

CBNAAT performed on FNAC samples shows excellent sensitivity and provides rapid results for diagnosing tuberculous lymphadenitis, while also identifying rifampicin resistance. This makes it an ideal point-of-care test for early treatment initiation, especially in resource-limited settings.

Zitieren

APA

Gupta, A. K., Yadav, P., Bhattacharya, S., Gautam, A. K., & Kumar, A. (2026). Assessment of rapid bedside point of care diagnostic utility of cartridge-based nucleic acid amplification test (CBNAAT) in the diagno. The Journal of Association of Chest Physicians, 14(1), 27-32. https://doi.org/10.4103/jacp.jacp_51_25

Vancouver

Gupta AK, Yadav P, Bhattacharya S, Gautam AK, Kumar A. Assessment of rapid bedside point of care diagnostic utility of cartridge-based nucleic acid amplification test (CBNAAT) in the diagno. The Journal of Association of Chest Physicians. 2026;14(1):27-32. doi:10.4103/jacp.jacp_51_25

BibTeX
@article{Gupta2026,
  author = {Gupta, Ashish Kumar and Yadav, Prashant and Bhattacharya, Somnath and Gautam, Aditya Kumar and Kumar, Adesh},
  title = {Assessment of rapid bedside point of care diagnostic utility of cartridge-based nucleic acid amplification test (CBNAAT) in the diagno},
  journal = {The Journal of Association of Chest Physicians},
  year = {2026},
  volume = {14},
  number = {1},
  pages = {27--32},
  doi = {10.4103/jacp.jacp_51_25}
}
Kostenlos starten →